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Gene silencing based on RNA-
guided catalytically inactive Cas9 
(dCas9): a new tool for genetic 
engineering in Leptospira
L. G. V. Fernandes1, L. p. Guaman2, s. A. Vasconcellos3, Marcos B. Heinemann3, M. Picardeau4 
& A. L. t. o. Nascimento  1
Leptospirosis is a worldwide zoonosis caused by pathogenic bacteria of the genus Leptospira, which 
also includes free-living saprophyte strains. Many aspects of leptospiral basic biology and virulence 
mechanisms remain unexplored mainly due to the lack of effective genetic tools available for these 
bacteria. Recently, the type II CRISPR/Cas system from Streptococcus pyogenes has been widely 
used as an efficient genome engineering tool in bacteria by inducing double-strand breaks (DSBs) in 
the desired genomic targets caused by an RNA-guided DNA endonuclease called Cas9, and the DSB 
repair associated machinery. In the present work, plasmids expressing heterologous S. pyogenes Cas9 
in L. biflexa cells were generated, and the enzyme could be expressed with no apparent toxicity to 
leptospiral cells. However, L. biflexa cells were unable to repair RNA-guided Cas9-induced DSBs. Thus, 
we used a catalytically dead Cas9 (dCas9) to obtain gene silencing rather than disruption, in a strategy 
called CRISPR interference (CRISPRi). We demonstrated complete gene silencing in L. biflexa cells when 
both dCas9 and single-guide RNA (sgRNA) targeting the coding strand of the β-galactosidase gene were 
expressed simultaneously. Furthermore, when the system was applied for silencing the dnaK gene, no 
colonies were recovered, indicating that DnaK protein is essential in Leptospira. In addition, flagellar 
motor switch FliG gene silencing resulted in reduced bacterial motility. To the best of our knowledge, 
this is the first work applying the CRISPRi system in Leptospira and spirochetes in general, expanding 
the tools available for understanding leptospiral biology.
The genus Leptospira includes both pathogenic and saprophytic species1,2. Pathogenic Leptospira are the etio-
logical agents of leptospirosis, while saprophytic bacteria are environmental free-living organisms. Humans are 
infected via contact with urine of wild or domestic animal carriers, either directly or indirectly through contam-
inated water or soil3.
Leptospires enter the host mainly via intact sodden or damaged skin or mucosa. The initial phase exhibits a 
wide range of nonspecific symptoms such as fever, chills, headache, and myalgia. Leptospirosis can progress to a 
severe condition known as Weil’s syndrome, corresponding to 5–15% of reported cases1. Another severe mani-
festation of the disease, leptospirosis-associated pulmonary hemorrhage syndrome, was first described in North 
Korea and China and has been increasingly reported worldwide4,5.
The mechanisms responsible for leptospirosis pathogenesis are still poorly understood, mainly due to the lack 
of genetic tools available for this pathogen. In the past decade, significant advances in the field have been made; 
Saint Girons et al.6 were able to engineer the LE1 prophage from L. biflexa into an E. coli-L.biflexa shuttle vec-
tor, only replicative in the saprophytic strains of Leptospira. A conjugative vector was also described7, and more 
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recently, Pappas et al.8 engineered a shuttle-vector replicative in E. coli and all leptospiral strains, including path-
ogens, favoring the creation of recombinant Leptospira spp. and gain-of-function phenotype studies, especially 
in the saprophyte strain.
Current techniques of gene inactivation rely on homologous recombination for targeted genetic knockout or 
random transposon insertion9–15. However, the frequency of knockout mutants recovered for homologous recom-
bination is extremely low, suggesting an inefficient capacity for double-recombination events. The transcription 
activator-like effectors (TALE) have also been used for specific gene silencing in both saprophytic and pathogenic 
strains, but this technique requires the synthesis of large and specific genes for each target16.
Recently, the CRISPR (clustered regularly interspaced short palindromic repeat) system has emerged as a 
powerful strategy for making mutants in both prokaryotic and eukaryotic cells17,18. This system has been found 
in the genomes of most Archaea and Bacteria, playing an important role in their immunity against phages and 
invading plasmids19,20.
To date, there are several CRISPR systems characterized, and among them, the Streptococcus pyogenes type II 
system has been the most explored. The requirement of only Cas9 nuclease for DNA cleavage and a single-guide 
RNA (sgRNA) for target specificity, has called the attention for the applicability of this system as a biotechnologi-
cal tool21,22. The CRISPR/Cas9 tool has been applied in several prokaryotes17,18,23 and eukaryotes24–29.
The generation of DSBs by RNA-guided Cas9 cleavage must be repaired for cell viability. The distinct path-
way used to repair induced DSBs dictates the type of genome editing: non-homologous end joining (NHEJ) and 
homology-directed repair (HDR)30–32.
Eukaryotes can repair DSBs introduced by Cas9 by directly ligating broken DNA ends using NHEJ in the 
absence of a repair template DNA molecule33,34. In contrast, Cas9 cleavage in the chromosome of most bacteria is 
reported to be lethal to the cells in the absence of a template for recombination35,36. This lethality could be over-
come by the use of a variant of Cas9, lacking nuclease activity, called catalytically dead Cas9 (dCas9), capable of 
binding specific DNA targets and preventing gene transcription, resulting in gene silencing rather than disrup-
tion37. This strategy, called CRISPRi, has been successfully applied in various organisms38–42.
In this work, we report the application of S. pyogenes CRISPR/Cas9 system in saprophytic L. biflexa aiming to 
generate mutants. The rational to employ L. biflexa was based to the fact that L. interrogans are fastidious bacteria 
while the saprophyte strain has higher transformation efficiency and shorter incubation time for colony forma-
tion. We describe for the first time DSB lethality in L. biflexa after RNA-guided Cas9 cleavage and the successful 
application of dCas9 and sgRNA-driven gene silencing in leptospiral cells.
The genes selected in this work were β-galactosidase, dnaK and fliG. In the case of β-galactosidase, the selec-
tion followed the rational employed by Pappas et al.16: readiness in phenotype evaluation (chromogenic substrate) 
and its non-essential nature, allowing colony recovering in case of gene inactivation/silencing. DnaK and FliG 
proteins were chosen due high protein expression and possible decrease in bacterial motility, respectively.
We believe that the application of this technology in pathogenic strains by generating mutants could advance 
our understanding of the mechanisms of leptospiral infection.
Material and Methods
Bacterial strains, plasmids and media. L. biflexa serovar Patoc strain Patoc1 was cultured at 28 °C under 
aerobic conditions, in liquid EMJH medium (Difco, BD, Franklin Lakes, NJ) and 1.2% noble agar (Difco) solid 
EMJH medium supplemented with 10% (vol/vol) Leptospira enrichment EMJH (Difco)43. When necessary, 
spectinomycin was added at 50 µg/mL.
E. coli DH5α (Invitrogen) and E. coli strain π144 were used for general cloning into pGKLep46 and pMaOri8 
plasmids, respectively. E. coli plasmids pCas and pTarget17 were utilized for Cas9 and sgRNA scaffold amplifica-
tion, respectively, and were a kind gift from Dr. Luiziana Ferreira da Silva (Laboratory of Bioproducts, Institute 
of Biomedical Sciences, University of São Paulo). The pdCas9-M-G6 plasmid45 was used for dCas9 amplification 
and was purchased from Addgene (https://www.addgene.org).
Evaluation of J23119, minimal borrelial flaB or lipL32 promoter activity in L. biflexa. The 
activity of the consensus bacterial promoter J2311946, minimal borrelial flaB47 or hypothetical minimal lipL32 
promoter (including the possible −10 and −35 regions) were evaluated in L. biflexa by heterologous protein 
expression. Briefly, J23119 promoter (35 bp) was genetically fused to lipL32 5′UTR, CDS and transcription termi-
nator, by PCR. Definition of 5′UTR was based on the results of TSS (transcription start site) defined by Zhukova 
et al.48. The first PCR was performed with primers J23LipL32 F1 and LipL32 R (Table 1), with L. interrogans 
serovar Copenhageni strain M20 genomic DNA. This PCR product was used as template for a second reaction 
containing primers J23LipL32 F2 and LipL32 R. The J23119 promoter nucleotide sequence was obtained from 
the BioBrick part BBa_J23119 (iGEM Registry of Standard Biological Parts, www.partsregistry.org). For minimal 
borrelial flaB promoter, the same 2-step PCR was used, first with primer flaBLip32 F1 and then with flaBLipL32 
F2, where both reactions were with LipL32 R as reverse primer. Primers p32min F and LipL32 R were used for 
amplification of minimal lipL32 promoter. Complete lipL32 (–334-TSS) promoter was used as control, obtained 
by PCR with primers p32 F and LipL32 R. The final PCR products containing SacI and XbaI restriction sites were 
digested and ligated into the pMaOri vector. As control, to rule out the possibility of spurious transcription, lipL32 
CDS and 5′UTR were cloned without any promoter at their 5′ end (LipL32control F and LipL32 R, Table 1). 
Recombinant plasmids were used to transform E. coli π1and L. biflexa serovar Patoc by electroporation as pre-
viously described49. Heterologous LipL32 protein expression was assessed by Western blotting and probing with 
mouse polyclonal anti-LipL32 antiserum (1:3,000) and horseradish peroxidase (HRP)-conjugated anti-mouse 
IgG antibodies (1:10,000, Sigma).
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Construction of Cas9-containing plasmids. The Leptospira-E. coli shuttle vector pMaOri8, replicative 
in saprophytic, intermediate and pathogenic strains, was used as backbone for cas9 gene ligation. Two promot-
ers directing cas9 transcription were used: the native cas9 promoter from S. pyogenes and the leptospiral com-
plete lipL32 gene promoter. pCas vector17 was used as template for cas9 amplification with Platinum® Taq DNA 
Polymerase High Fidelity (Thermo). To obtain the native promoter plus cas9 CDS, pCas plasmid was utilized as 
template with primers Cas9 F and Cas9 R (Table 1), containing NotI and XbaI restriction sites at the 5′ end for 
further ligation at pMaOri. The genetic fusion of lipL32 promoter (p32) to the cas9 CDS was achieved by the 
megaprimer strategy. First, the lipL32 promoter was amplified from L. interrogans genomic DNA with primers 
p32Cas9 F and Cas9fusion (Table 1), the latter containing a complementary sequence to the end of the promoter 
and a 5′overhang with the first 30 nucleotides of cas9 CDS; the amplicon was used as a forward primer along with 
pCas R to generate the fused gene, which was re-amplified with p32 F and Cas9 R. PCR products were digested 
with NotI and XbaI and ligated into the corresponding sites of pMaOri, transformed in E. coli π1 strain by heat 
shock and transformants were plated onto LB plates containing spectinomycin (50 µg/mL) and dT (0.3 mM). The 
plasmids were designated pMaOriCas9 (native promoter, pNative) and pMaOri.p32Cas9 (lipL32 promoter) and 
clones with no mutation at cas9 gene were used for further studies.
Polyclonal antiserum production. L. interrogans serovar Copenhageni strain Fiocruz L1–130 genomic 
DNA was used to produce recombinant DnaK (LIC_RS02730, namely LIC10524) and FliG (LIC_RS00120, 
namely LIC10023). Recombinant proteins (10 µg) were used to immunize BALB/c mice for polyclonal antiserum 
production. Both antisera are able to recognize L. biflexa homologous proteins due to their high similarity. All 
animal studies were approved by the Ethical Committee for Animal Research of the Instituto Butantan, Brazil, 
Primer Sequence (5′ → 3′) Restriction Site
pMaOri F AGTGACACAGGAACACTTAACG —
pMaOri R TATATTCTGTCCACATTTGTGG —
Cas9 F ATCGGCGGCCGCGGTTTGCAGTCAGAGTAGAATAG NotI
Cas9 R ATCGTCTAGATTAAGAAATAATCTTCATCTA XbaI
p32Cas9 F GCATAGAGCGGCCGCGAACAAGAAAGAGTCAGAG NotI
Cas9fusion ATATCTAAGCCTATTGAGTATTTCTTATCCATAGACT CTCCTTAGTTAGG —
Cas9seq1 ATATTAAACTAATTTCGGAG —
Cas9seq2 GTAGATTCTACTGATAAAGC —
Cas9seq3 TCAGCTTCAATGATTAAACG —
Cas9seq4 TGAACGCATGACAAACTTTG —
Cas9seq5 AATTGATTAATGGTATTAGG —
Cas9seq6 ACAAAGTTTCCTTAAAGACG —
Cas9seq7 TGGGGAAACTGGAGAAATTG —
Cas9seq8 AATCAGTGAATTTTCTAAGC —
Spc F CGATTCAAACATTAAAAATCG —
Spc R CACTCACCGTATATAAATTCTC —
J23LipL32 F1 GCTCAGTCCTAGGTATAATACTAGTCTAACTAAGGAG AGTCTATG —
J23LipL32 F2 GCATAGAGAGCTCTTGACAGCTAGCTCAGTCCTAGGTA TAATACTAGTCTAAC SacI
flaBLip32 F1 TTTTTTAATTTTTGTGCTATTCTTTTTAACCTAACTAAGG AGAGTCTATG —
flaBLip32 F2 TAGAGAGCTCTTCTTTTTTTTTAATTTTTGTGCTATTCTT SacI
p32min F TAGAGAGCTCGATTTACAAAAAATTCCTAAG SacI
p32 F TAGAGAGCTCGAACAAGAAAGAGTCAGAG SacI
LipL32 R GCATAGATCTAGATATTCAAATGTAGTTTTAGG XbaI
pMaOri2 F ACGCAATGTATCGATACCGAC —
pMaOri2 R ATAGGTGAAGTAGGCCCACCC —
p32XmaIF atcgaCCCGGGGAACAAGAAAGAGTCAGAG XmaI
Scaffold R tcgaCCCGGGAAAAAAAGCACCGACTCGGTGCCACTTTTTCAAG XmaI
sgRNAbgal1 F CATACCGTGATTTTCAATTTGCCAACCTACAACCGGTTTTAGAGCTAGAA —
sgRNAbgal2 F CATACCGTGATTTTCGGGAACCACCCCGCGGTTGTGTTTTAGAGCTAGAA —
sgRNAdnaK1 F CATACCGTGATTTTCACACGAGCCGCAATTTCTTGGTTTTAGAGCTAGAA —
sgRNAdnaK2 F CATACCGTGATTTTCAGCCGGTGACGAATCAAAGAGTTTTAGAGCTAGAA —
sgRNAfligF CATACCGTGATTTTCAACCGCTACCAAAAAGATGGGTTTTAGAGCTAGAA —
qPCRBgal F ATTGTGACAGCAATGGCAAA —
qPCRBgal R GTGGGGAATAATCCACATCG —
qPCR16S F GGTGCAAGCGTTGTTCGG —
qPCR16S R GATATCTACGCATTTCACCGC —
Table 1. Sequences and restriction sites of the primers used in this study. *Underlined are the restriction sites.
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registered under protocol no8543200617. The Committee for Animal Research in Instituto Butantan adopts the 
guidelines of the Brazilian College of Animal Experimentation (COBEA.)
Validation of Cas9 expression in recombinant E. coli and L. biflexa. Recombinant E. coli and L. 
biflexa containing pMaOri, pMaOriCas9 or pMaOri.p32Cas9 were recovered from the medium by centrifuga-
tion (6,000 rpm, 15 min), washed twice in PBS and resuspended in the same buffer. Final bacterial suspensions 
were diluted and normalized to an absorbance of 10 at 420 nm. Samples were then mixed with denaturing buffer 
(10% SDS, 50% glycerol, 0.5% bromophenol blue, 3% β-mercaptoethanol) and heated for 10 min at 96 °C, and 
proteins in 20 μL of sample were separated by 7.5% SDS-polyacrylamide gel electrophoresis (SDS-PAGE) for 2 h. 
Proteins were transferred onto nitrocellulose membranes (Hybond ECL; GE Healthcare) on semidry equipment, 
and transfer efficiency was assessed by Ponceau S staining (Sigma). Membranes were blocked with 10% nonfat 
dry milk in PBS containing 0.05% Tween 20 (PBS-T) and then incubated with mouse monoclonal anti-Cas9 anti-
bodies (SAB4200701, 1:10,000 in PBS-T containing 1% milk, Sigma) for 1 h at room temperature. After washing, 
detection of bound antibodies was performed by incubation with HRP-conjugated anti-mouse IgG (1:10,000, 
Sigma) for 1 h. Incubation with polyclonal anti-DnaK (1:1,000) was used as constitutive and loading control for 
leptospiral cell extracts. Protein reactivity was revealed by using SuperSignalTM West Dura Extended Duration 
Substrate (Thermo Scientific) and the luminescence generated was detected with the aid of an Amersham Imager 
600 (GE).
Assessment of Cas9 nuclease activity in E. coli. Competent E. coli cells containing the plasmid pMaOr-
iCas9 or pMaOri.p32Cas9 or wild-type strain cells were transformed with 10 ng of plasmid pGKLep4 or pGKLep4 
containing the J23119 promoter directing the transcription of sgRNA targeting the E. coli β-galactosidase gene 
(b0344) (pGKLep4sgRNAbgalEcoli) or leptospiral β-galactosidase (LEPBI_RS00135), as control. After transfor-
mation, cells were seeded on LB plates supplemented with both spectinomycin (50 μg/mL, selection of pMaOri 
backbone plasmids) and kanamycin (50 μg/mL, selection of pGKLep4 backbone plasmids). Wild-type cells trans-
formed with pGKLep4 plasmid were seeded on LB plus kanamycin plates.
Selection of protospacer, constructions of sgRNA cassettes and plasmid ligation. Desired gene 
sequences were obtained from GenBank (https://www.ncbi.nlm.nih.gov/genbank/) and submitted to the web-
server CHOPCHOP (http://chopchop.cbu.uib.no/)50, with the basic input comprising CRISPR/Cas9 and PAM 
(protospacer adjacent motif) NGG. Protospacers were chosen on the basis of their score and proximity to the 
N-terminus of the resulting proteins. The selected protospacers, β-galactosidase, dnaK and fliG, are shown in 
Table 2. Protospacer transcription along with sgRNA scaffold for Cas9 recognition was driven by the leptos-
piral lipL32 promoter, the same sequence used for Cas9 expression on pMaOri.p32Cas9. First, sgRNA scaffold 
sequence contained in the pTarget vector17 was amplified by PCR with primers sgRNAF (depending on the proto-
spacer) and Scaffold R. At the 5′ end of each forward primer, a 20 nt sequence regarding the selected protospacer 
sequence was included, along with a sequence complementary to the end of the lipL32 promoter. Amplicons were 
purified and used as reverse megaprimer in a second PCR mixture containing p32XmaI F as forward primer. 
Fused amplicon was purified, digested with XmaI restriction enzyme and then ligated to pMaOriCas9 or pMaOri.
p32Cas9 vectors previously digested with the same enzyme. Ligation reactions were used to transform E. coli π1 
cells, which were seeded on LB plus spectinomycin and dT (0.3 mM). Final recombinant plasmids were confirmed 
by colony PCR (pMaOri2 F and pMaOri2 R) and sequencing. L. biflexa cells were grown in liquid EMJH and then 
transformed by electroporation with recombinant pMaOriCas9 or pMaOri.p32Cas9 containing different sgRNA.
Construction of dCas9-expressing plasmids. The pdCas9-M-G6 plasmid45 was used as template in PCR 
mixture containing Cas9 F and Cas9 R (Table 1), with NotI and XbaI restriction sites at the 5′ end for later ligation 
to the pMaOri vector. PCR conditions and ligation parameters were the same as described above for pMaOriCas9 
construction. After confirmation of recombinant plasmid, pMaOri.dCas9 was digested with XmaI for inclusion 
of sgRNA cassettes. Plasmids containing sgRNA sequence alone were also constructed and employed as control 
for gene silencing. Briefly, sgRNA cassettes were amplified, digested with KpnI and BamHI enzymes and ligated 
at the same restriction sites in the pGKLep4 plasmid.
Validation of β-galactosidase gene silencing in L. biflexa. Confirmation of genetic knockdown was 
performed by β-galactosidase colorimetric assay, according to the methods described by Pappas and Picardeau16, 
with slight modifications. Briefly, L. biflexa cultures were counted by using a Petroff-Hausser counting chamber 
and a total of 3 × 108 cells per sample were centrifuged at 4,000 × g for 15 min. The supernatant was discarded and 
cells resuspended in 1 mL of Z buffer (pH 7, containing 130 mM monosodium phosphate, 40 mM disodium phos-
phate, 10 mM potassium chloride, 2 mM magnesium sulfate and 40 mM β-mercaptoethanol). The absorbance 
sgRNA Protospacer sequence Pairing to
sgRNAbgal1 AATTTGCCAACCTACAACCG Coding strand
sgRNAbgal2 GGGAACCACCCCGCGGTTGT Template strand
sgRNAdnaK1 ACACGAGCCGCAATTTCTTG Coding strand
sgRNAdnaK2 AGCCGGTGACGAATCAAAGA Template strand
sgRNAfliG AACCGCTACCAAAAAGATGG Coding strand
Table 2. Protospacers selected for gene targeting.
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of each sample was measured at 420 nm, and then, 40 µL of chloroform and 30 µL of 0.1% SDS were added. 
Samples were vortexed and then allowed to stand at 30 °C for 5 min. Right after incubation, 200 µL of 13.27 mM 
o-nitrophenyl-β-D-galactopyranoside (ONPG, Sigma) in Z buffer were added to the samples. After development, 
the reaction was stopped by mixing 250 µL of sample with 100 µL of 1 M sodium carbonate. The color change was 
evaluated using a spectrophotometer to measure absorbance at 420 nm. Also, X-gal chromogenic substrate was 
used to assay for β-galactosidase activity. Briefly, 5 × 108 leptospiral cells were resuspended in 300 µL of PBS con-
taining 5 mg/mL X-gal, and the blue color was determined by spectrophotometer readings at 595 nm.
RNA extraction and qPCR. Leptospiral cells in late-log phase in 30 mL EMJH medium were collected by 
centrifugation (6,000 rpm for 15 min) in RNase-free tubes. The resulting pellet was resuspended in 1 mL of Trizol 
reagent (Invitrogen) and RNA was purified according to the manufacturer’s instructions. cDNA was synthesized 
using 2 µg total RNA, the SuperScript III reverse transcriptase kit (Invitrogen) and random hexamers, according 
to standard protocols. RT-qPCR was performed in a reaction volume of 20 μL containing 1 µL of cDNA, 400 nM 
of each oligonucleotide and 10 μL of SYBR Green PCR Master Mix (Applied Biosystems), as recommended by the 
manufacturer. All reactions were performed in triplicate in 96-well optical plates. Negative controls using all the 
reagents but cDNA were used (NTC, no template control). Cycling conditions were: 50 °C for 2 min and 95 °C for 
10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C for 30 s. The relative gene expression among the L. biflexa 
cells containing different plasmids was determined using the 2−ΔΔCT method. The constitutive 16 S gene was 
used as the internal normalization control.
Phenotype stability experiments. Gene silencing stability was performed as follows: L. biflexa cells 
containing pMaOri.dCas9sgRNAbgal1 grown in EMJH plus spectinomycin were transferred to new EMJH liq-
uid medium (1:10 dilution) with no antibiotic addition. Serial passages were performed and at each passage, 
β-galactosidase activity was measured, as described above, and compared to that exhibited by leptospires grown 
in EMJH plus antibiotic (100% gene silencing). Confirmation of plasmid maintenance was performed by PCR 
with pMaOri2 primer.
Results
Assessment of different promoter activity in L. biflexa. We evaluated different minimal promoters 
to determine which one is efficiently recognized by L. biflexa transcriptional apparatus. Figure 1A describes the 
different constructions used; the consensus E. coli promoter J23119 (35 nt)46, the previously characterized mini-
mal borrelial flaB promoter (35 nt)47 and a hypothetical minimal lipL32 promoter (35 nt), comprising the -10 and 
-35 sequences, were used. As positive control, the complete lipL32 promoter (334 nt) was utilized, and to rule out 
the possibility of spurious transcription in the plasmid used, the lipL32 gene was also cloned without any pro-
moter sequence at its 5′ end. Inserts were ligated into pMaOri and recombinant plasmids were used to transform 
L. biflexa; transcriptional activity of different promoters was assessed indirectly by heterologous LipL32 protein 
detection.
After Western blotting, strong LipL32 reactivity was obtained only with the complete lipL32 promoter, 
denoting that leptospires were not effective in recognizing the minimal promoters tested (Fig. 1B and Fig. S1). 
Accordingly, no band was detected when no promoter sequence was included, indicating that no spurious tran-
scription occurred in pMaOri. DnaK protein was utilized as a loading control.
On the other hand, strong LipL32 signal was detected in cell extracts from E. coli π1 cells containing the con-
structs in which J23119 and flaBmin promoters were used, followed by a modest protein signal when leptospiral 
lipL32 promoter was used. These results reinforced the notion that leptospiral cells were indeed defective in 
Figure 1. Assessment of promoter activity in L. biflexa. (A) L. interrogans lipL32 gene CDS, 5′UTR plus 
transcription terminator were genetically fused to different promoters. L. biflexa cell were electroporated 
with the different recombinant plasmids and promoter activity was indirectly accessed by probing whole cell 
extracts with anti-LipL32 antiserum for detecting heterologous LipL32 expression (B). Anti-DnaK antiserum 
was employed as a loading control. LipL32 expression was assayed in both E. coli (E) and L. biflexa (L). As a 
negative control, a construction in which no promoter was added to rule out the possibility of spurious DNA 
transcription. The E. coli and L. biflexa protein blottings are from different gels (individually depicted in Fig. S1). 
For comparative purposes, the lanes were cut and organized by promoters.
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recognizing these minimal promoters, and therefore, only the complete lipL32 promoter (p32) was selected for 
further use.
Heterologous Cas9 expression in L. biflexa and nuclease activity validation in E. coli. The 
schematic representation of the plasmids constructed in this work along with important features and unique 
restriction sites are presented in Fig. 2A. Due to the pMaOri backbone, both plasmids pMaOriCas9 and pMaOri.
p32 Cas9 could be used to transform Leptospira spp. by electroporation or conjugation.
Cas9 expression in E. coli was only detected in the cells containing the pMaOriCas9 plasmid (Fig. 2B, E. coli, 
lane 2), leading us to conclude that these bacteria could recognize the S. pyogenes promoter, as expected17, but 
were not very effective in recognizing the leptospiral lipL32 promoter (lane 3). Surprisingly, L. biflexa cells could 
recognize both promoters, because Cas9 expression was detected in recombinant bacteria containing pMaOri-
Cas9 (Fig. 2B, L. biflexa, lane 2) and pMaOri.p32 Cas9 (lane 3), in similar fashion. DnaK protein was employed as 
a loading control. It is worth noting that no significant shift in the growth curve was observed when comparing 
Cas9-expressing cells to leptospiral cells containing empty pMaOri vector (data not shown).
To confirm whether the cas9 genes ligated into the pMaOri backbone were indeed mutation-free and the cor-
responding protein functional and able to cleave DNA, E. coli cells containing pMaOriCas9 or pMaOri.p32Cas9 
(spectinomycin resistance) were made competent and then transformed with a second plasmid, pGKLep4, empty 
or containing an expression cassette for sgRNA against β-galactosidase of E. coli or L. biflexa, used as negative 
control; sgRNA transcription was driven by the J23119 promoter. When E. coli containing either pMaOriCas9 
or pMaOri.p32Cas9 were transformed with empty pGKLep4 or pGKLep4sgRNAbgal (targeting the leptospiral 
gene, kanamycin resistance), a large number of colonies were isolated on plates with double antibiotic selection 
(Fig. 2C). The discrepancy in absolute number regarding the pMaOriCas9 and pMaOri.p32Cas9 groups was 
possibly due to competence differences. Accordingly, when we used pGKLep4sgRNAbgalEcoli, no colonies were 
observed (Fig. 2C), indicating that the Cas9 protein retained nuclease activity and was able to induce DSBs in the 
E. coli genome, causing a lethal phenotype35. These results suggested that Cas9 expressed by both vectors is func-
tional and able to cleave genomic DNA, and although no Cas9 band was detected by Western blotting in E. coli 
Figure 2. Heterologous expression of Cas9 in L. biflexa cells and nuclease activity validation in E. coli. (A) Map 
of the plasmids obtained in this work, depicting important features and unique restriction sites. (B) Imunoblots 
of E. coli and L. biflexa containing wild type pMaOri (1), pMaOriCas9 (2) or pMaOri.p32Cas9 (3) with anti-
Cas9 and anti-DnaK antibodies. Data of E. coli and L. biflexa come from different blottings. (C) Transformation 
efficiency of E. coli cells containing plasmids pMaOriCas9, pMaOri.p32Cas9 or no plasmid with plasmids 
pGKLep4 (wild type) or pGKLep4 containing J23119 promoter directing the transcription of sgRNA targeting 
the E. coli βgal gene (pGKLep4sgRNAbgalEcoli) or an unrelated sequence (leptospiral β-galactosidase, 
pGKLep4sgRNAbgal), as control. After transformation, cells were seeded onto LB plates supplemented with 
spectinomycin and kanamycin. As a control, wild type cells transformed with pGKLep4 plasmids were seed 
in LB plus kanamycin plates. Cell counting are presented as average plus standard deviation of 3 independent 
experiments.
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harboring pMaOri.p32Cas9 (Fig. 2B, E. coli, lane 3), it is likely that this protein was present in low copy number, 
possibly due to low lipL32 promoter activity in E. coli, as observed in Fig. 1B.
Cas9 and sgRNA co-expression is lethal to L. biflexa. Protospacer to target the non-essential 
β-galactosidase gene in L. biflexa was selected by the CHOPCHOP50 webserver. Briefly, 20-mer sequences con-
taining a 3′PAM, in this case NGG for S. pyogenes Cas9, were selected and transcribed along with a scaffold 
sequence containing a Cas9 handle and an intrinsic transcription terminator (Fig. 3A). The first 20 nucleotides of 
the sgRNA determine target specificity by Watson-Crick base pairing, and therefore, are easily editable.
Wild-type L. biflexa cells were transformed with pMaOriCas9 or pMaOri.p32Cas9 plasmids containing the 
sgRNA constructs. Transcription of the single-guided RNA targeting the L. biflexa β-galactosidase was driven by 
the strong leptospiral lipL32 gene promoter. The plasmids without the sgRNA sequences were used for control.
The data obtained from three independent experiments showed that, even with different transformation rates 
(ranging from 75 to 880 and 436 to 2530 per µg DNA for pMaOriCas9 and pMaOri.p32Cas9, respectively), a 
pattern was clearly observed: no or very few colonies were obtained when both Cas9 and sgRNA were expressed 
(Fig. 3B), indicating that DSBs were lethal for L. biflexa, as observed for most prokaryotes, including E. coli36. 
Also, these results indicated that the protospacer sequences selected for sgRNA composition could successfully 
direct the Cas9 nuclease to the desired target sites.
Accordingly, the few colonies obtained in the third experiments after transformation with pMaOri.p32Cas9 
containing sgRNAbgal1 or 2 were evaluated regarding Cas9 expression by Western blotting and sgRNA cassette 
presence by PCR with pMaOri2 F and R (Table 1). Our results indicated that neither Cas9 nor sgRNA were 
present in these bacteria (data not shown), suggesting that those colonies were spontaneous mutants resistant to 
spectinomycin. Indeed, these colonies, when investigated, displayed no decrease in β-galactosidase activity (data 
not shown).
Development of a gene knockdown strategy using dCas9 and sgRNA. As DSBs were shown to be 
lethal to L. biflexa cells, a catalytically inactive (“dead”) Cas9 (dCas9) was used. This system, in which the Cas9 
enzyme has two silencing mutations in nuclease domains, is utilized to target gene regulation rather than disrup-
tion, by blocking RNA polymerase from promoter recognition or elongation37 (Fig. 4A). Since the sgRNA used 
in this work are able to pair within the β-galactosidase (LEPBI_RS00135) CDS (sgRNAbgal1 and sgRNAbgal2 
pairing to the coding and template strand, respectively), a blocking of RNA polymerase movement is expected.
Figure 3. sgRNA-directed Ca9 genomic cleavage is lethal to L. biflexa cells. (A) Protospacers are selected based 
on the presence of a 3′ NGG (PAM). Schematic representation of sgRNA sequence is also shown; the first 20–25 
nucleotides, starting from the transcription start site (TSS) are variable according to the gene target, followed 
by a sequence folded in a hairpin-like structure responsible for Cas9 interaction. Transcription termination 
is dictated by the presence of a S. pyogenes intrinsic terminator. (B) pMaOriCas9, pMaOri.p32Cas9 plasmids, 
alone or containing different sgRNA targeting the β-galactosidase gene were used to electroporate competent 
L. biflexa cells, which were seeded onto EMJH plates plus spectinomycin and grown colonies were counted 
and normalized per µg of DNA. Different experiments are presented and for each, cell counting is presented as 
average plus standard deviation of 3 different plates.
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L. biflexa wild-type cells were transformed by electroporation with pMaOri.dCas9 alone or containing sgRN-
Abgal1 or sgRNAbgal2; pMaOriCas9 alone or containing sgRNA were also utilized. As expected, no colonies 
were observed when wild-type Cas9 enzyme was expressed along with sgRNAs, corroborating DSB lethality. 
Accordingly, when dCas9 enzyme was expressed along with sgRNAs, a large number of bacteria were recovered 
(over 1000 colonies per µg DNA), comparable to the plasmids expressing only Cas9 or dCas9 (Fig. 4B).
To confirm that indeed the cells were harboring the plasmids containing both dCas9 and sgRNA (pMaOri.
dCas9sgRNAbgal), different colonies (a-d) were selected from each plate and assessed for dCas9 expression by 
Western blotting and probing pooled total cell extracts with anti-Cas9 antibodies (Fig. 4C) and for the presence 
of the sgRNA cassette by PCR using pMaOri2 primers (Fig. 4D).
Validation of β-galactosidase gene silencing. Having recovered leptospiral cells transformed with plas-
mids containing both dCas9 and sgRNA, we decided to follow up and confirm whether gene silencing occurred: 
different colonies were isolated from plates and grown in liquid EMJH plus spectinomycin, and cells were evalu-
ated regarding β-galactosidase activity by using two different chromogenic substrates, ONPG and X-gal. Enzyme 
activity was evaluated on a time basis, and when ONPG was utilized, there was a slight decrease (around 33%) in 
leptospiral cells when dCas9 was expressed along with sgRNAbgal2 compared to the cells expressing dCas9 alone 
(Fig. 5A). On the other hand, a complete gene silencing was observed when sgRNA was designed to hybridize to 
the coding strand (sgRNAbgal1), even when the reaction proceeded for 24 h, indicating a 100% reduction of gene 
transcription (Fig. 5A).
Figure 4. dCas9 and sgRNA simultaneous expression is tolerated by L. biflexa cells. dCas9, a nuclease-depleted 
variant of Cas9, when directed by a sgRNA, is capable of binding to specific target sequences, causing gene 
silencing rather than disruption due to a steric blockage of RNA polymerases elongation. sgRNA pairing 
to both coding (sgRNAbgal1) and template (sgRNAbgal2) strands were constructed (A). pMaoriCas9 and 
pMaOridCas9, alone or containing distinct sgRNA, were used to electroporate L. biflexa cells. Colonies were 
counted (B) and screened for dCas9 expression, by western blotting with monoclonal anti-Cas9 antibodies (C). 
Different colonies (a-d) were also assayed for sgRNA presence by PCR using flanking primers; (D) purified 
plasmids were employed as positive control (C+).
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Gene silencing was also confirmed when X-gal substrate was used (Fig. 5B), with cells displaying reductions 
comparable to the previous experiment, corroborating the successful effect of sgRNAbgal1 on gene silencing. 
The major gene silencing effect of sgRNA targeting the coding strand was previously shown in Staphylococcus 
aureus38, indicating that our newly described system is feasible in L. biflexa.
Since the repression of gene expression is thought to occur at the transcriptional level, that is, sgRNA-directed 
dCas9 bound to DNA blocks RNA polymerase extension, we aimed to detect β-galactosidase mRNA levels in 
knockdown and control cells by qPCR. Consistent with the enzyme assays, bacteria expressing sgRNAbgal1 dis-
played a marked decrease in β-galactosidase mRNA levels, followed by a modest reduction in cells expressing 
sgRNAbgal2, compared to those expressing only dCas9 (Fig. 5C).
To rule out the possibility of gene silencing due to RNA-RNA duplex rather than CRISPRi, L. biflexa cells were 
transformed with plasmids containing sgRNA sequence alone and the recovered colonies display no reduction 
upon β-galactosidase activity (Fig. S2), confirming that dCas9 is necessary for gene silencing.
To reinforce the successful application of the system, the whole colony population grown in EMJH plus 
spectinomycin was evaluated. Briefly, 100 µL of 20 mg/mL X-gal solution were spread on the plates, which were 
then incubated at 30 °C for 24 h. Colonies containing pMaOri.dCas9 or pMaOri.dCas9sgRNAbgal2 showed a 
strong blue color (Fig. 5D, DB, dark background, WB, white background), corresponding to β-galactosidase 
activity detected in those cells (Fig. 5A,B); even though sgRNAbgal2 could reduce enzyme activity slightly, the 
qualitative nature of these experiments did not allow us to determine any measurable decrease. In contrast, all 
Figure 5. Total β-galactosidase gene silencing obtained by dCas9 expression along with sgRNA pairing to the 
coding strand. Different colonies were selected from the EMJH plates, grown in liquid media and then evaluated 
regarding β-galactosidase activity in a time-basis, employing ONPG substrate (A) and X-gal (B). Graphics show 
the average of densitometric reading plus standard deviation of 4 biological replicates. For statistical analysis, 
absorbance values displayed by cells containing dCas9 and sgRNA were compared to those displayed by cells 
containing pMaOri.dCas9 plasmid alone by Student’s two-tailed t test (*P < 0.05). (C) Relative transcription 
level of β-galactosidase gene in knockdown strains by qPCR. Presented values represent the mean plus standard 
deviation measurements. For statistical analyses, the absorbance or relative expression values displayed by the 
knockdown mutants were compared to those presented by the cells containing pMaOri.dCas9 alone (*P < 0.05). 
(D) X-gal solution was spread onto EMJH plates containing grown colonies, containing either pMaOridCas9 or 
this plasmid with sgRNA cassettes. Figures are presented against dark (DB) and white (WB) background. (E) L. 
biflexa cells containing pMaOri.dCas9sgRNAbgal1 grown in EMJH plus spectinomycin were transferred to new 
EMJH liquid medium (1:10 dilution) with no antibiotic (No Spc). Serial passages were performed (1–8) and at 
each passage, β-galactosidase activity was measured. The activity displayed by cells containing pMaOri.dCas9 
plasmid was considered 100%.
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colonies containing pMaOri.dCas9sgRNAbgal1 appeared white (Fig. 5D), corroborating the complete gene 
silencing in our system.
When phenotype stability was evaluated, even after 8 passages in EMJH medium with no antibiotic selection, 
gene silencing could still be observed (Fig. 5E), denoting plasmid stability in leptospiral population, as previously 
shown8, which was confirmed by PCR assay (data not shown); accordingly, addition of spectinomycin in EMJH 
medium at the eighth passage completely restored full gene silencing by selecting plasmid-containing leptospires 
(Fig. 5E).
DnaK gene silencing prevents L. biflexa growth in plates. L. biflexa cells were transformed with the 
plasmid pMaOri.dCas9 alone or containing sgRNA targeting the coding (sgRNAdnaK1) or template (sgRNAd-
naK2) strand of the dnaK (LEPBI_RS16560) gene CDS. After five independent experiments, despite the variation 
at transformation rates, no cells containing dCas9 and sgRNAdnaK1 could be recovered, even though a large 
number of colonies were observed in plates with pMaOri.dCas9 alone or containing the sgRNA hybridized to 
the template strand (sgRNAdnaK2) (Fig. 6A). It is worth mentioning that the few colonies obtained after trans-
formation with pMaOri.dCas9sgRNAdnaK1 in experiment number three, when assayed by PCR, were negative 
for Cas9 CDS and sgRNA cassette (data not shown). When the protein (Fig. 6B) and mRNA levels (Fig. 6C) were 
assessed in the recovered leptospiral cells containing pMaOri.dCas9sgRNAdnaK2 in comparison to pMaOri.
dCas9 alone, a slight reduction was observed. Despite this reduction in DnaK expression, no difference in growth 
curves was observed (data not shown).
Flagellar motor switch fliG gene silencing reduces bacterial motility in plate. A sgRNA cassette 
was constructed aiming hybridization with the coding strand of the fliG gene (LEPBI_RS16770) and ligated into 
pMaOri.dCas9 plasmid. L. biflexa cells were transformed with either pMaOri.dCas9 or pMaOri.dCas9sgRNAflig. 
The time required for the appearance of colonies of the latter group was considerably longer (~14 days vs 8 days). 
Similar number of colonies were obtained per µg of DNA employed (not shown) and a clear phenotype could 
be observed regarding their morphology, where smaller colonies were observed when dCas9 and sgRNA were 
expressed (Fig. 7A). After 18 days growth, distinct colonies were visualized at light microscope and diameter were 
calculated: bacteria transformed with pMaOri.dCas9 alone presented an average 0.69 ± 0.18 mm diameter, in 
contrast to 0.17 ± 0.02 mm calculated for colonies containing pMaOri.dCas9sgRNAflig (Fig. 7B), denoting defi-
ciency in motility. Longer time required for growth and smaller colonies were also observed in fliG2 (BB_0290) 
mutants in the spirochete Borrelia burgdorferi51.
Colonies were selected for growth in liquid media (no difference in growth curve, data not shown) and recov-
ered bacteria were assayed regarding FliG protein expression, probing cell extracts with mouse anti-recombinant 
FliG. The phenotype observed was correlated with an abolished protein expression (Fig. 7C), indicating that FliG 
is necessary for bacterial motility. The data strengthened the importance of the system to studying leptospiral 
biology.
Discussion
A pivotal step for understanding the basic biology and virulence of microorganisms is the ability to generate 
genetic mutations to assess the resulting phenotype18. Despite the recent advances in genetic tools for functional 
genomic analysis in many microbial species, target mutations or gene silencing in some microorganisms remains 
difficult to implement.
Figure 6. sgRNA targeting the coding strand of dnaK gene prevents leptospiral growth in plates. L. biflexa 
cells were transformed with the plasmid pMaOri.dCas9 alone or containing sgRNA targeting the coding 
(sgRNAdnaK1) or template (sgRNAdnaK2) strand of the dnaK gene. Colonies were counted (A) and DnaK 
protein levels were evaluated by western blotting probing cell extracts with anti-DnaK (B, upper panel). 
Coomassie blue staining (B, lower panel) was used as loading control. (C) Relative transcription level of dnaK 
gene in knockdown strain by qPCR. Values are presented as average plus standard deviation of 3 replicates. 
For statistical analyses, relative expression values displayed by the knockdown mutant were compared to those 
presented by the cells containing pMaOri.dCas9 alone (*P < 0.05).
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Genetic manipulations in Leptospira spp. have expanded in the past years, but are still limited. Random trans-
poson insertion libraries have been performed in both pathogenic9 and saprophyte strains10. Although these 
studies have shed light on various gene functions and their role in pathogenesis and basic biology52–58, screening 
libraries of mutants is laborious, and in most cases, there is no evidence of the expected phenotype, since the 
products of several leptospiral genes are assigned as hypothetical proteins59,60. Moreover, there is no guarantee 
that the gene of interest will be knocked out as it is not possible to fully saturate the genome with all possible 
transposon insertions9.
The ability to knockout specific target genes in Leptospira was achieved by the use of homologous recombina-
tion, by using suicide plasmids containing an antibiotic resistance cassette flanked by homology arms13. However, 
as the recombination events are not induced by DSBs, the recovery rate of actual mutants is extremely low, and in 
most cases, only a single recombinant event is observed, culminating in whole plasmid insertion.
Pappas and Picardeau16 made the first attempt to control gene expression in L. biflexa, targeting the 
β-galactosidase gene by transcription activator-like effectors (TALEs). TALEs are a group of repressors that can 
modulate transcriptional activity by directly binding to a targeted sequence within the host genome61. Although 
encouraging results were obtained, this tool requires the design of one protein for each gene target, making this 
technique costly and laborious62.
The prokaryote immunity type II CRISPR/Cas system is emerging as a powerful biotechnological tool for 
manipulating the genome in various organisms. The Cas9 enzyme is an RNA-guided DNA endonuclease that 
can be easily programmed to target genomic sites depending on the interaction with the guide RNA sequence63.
Plasmids expressing heterologous S. pyogenes Cas9 in L. biflexa cells were generated, and the enzyme could 
be expressed with no apparent toxicity to leptospiral cells. Since Cas9 must be directed to its target sequence 
for genomic DSBs, we included different sgRNA in the Cas9-expressing plasmids for a one-step mutagenesis 
methodology. The β-galactosidase gene was selected due to its non-essential nature in Leptospira spp. and ease of 
evaluating a mutant’s phenotype16.
However, no colonies could be recovered after transformation with plasmids containing both Cas9 and 
sgRNA, even though a large number of colonies were obtained when the Cas9-plasmid alone was utilized. These 
results led us to conclude that as in most prokaryotic cells64,65, DSBs are lethal to L. biflexa cells, indicating the 
lack of NHEJ machinery.
In bacteria, the NHEJ system, when present, is carried out by that homologous to the eukaryotic Ku pro-
tein and ATP-dependent DNA ligase66–68. Only a few bacteria have annotated genes coding for Ku and the 
ATP-dependent LigD proteins, including the human pathogens Mycobacterium tuberculosis, Pseudomonas aerug-
inosa, and Bacillus anthracis69. Some bacterial species, such as Clostridium cellulolyticum, are killed by genomic 
DSBs generated by Cas9 cleavage despite the presence of NHEJ systems70. The NHEJ system was not found in the 
Leptospira genomes.
To overcome DSB lethality in some bacteria and achieve gene silencing rather than disruption, a newer vari-
ant of the CRISPR/Cas9 technology has been developed. CRISPRi consists in a catalytically “dead” Cas9 (dCas9) 
with a point mutation within the nuclease domains18,38. This protein, when interacting with sgRNA, is capable of 
binding to genomic loci causing RNA polymerase steric hindrance, blocking transcription initiation, if bound to 
the promoter, or elongation, if bound to the CDS.
We adapted the dCas9 methodology to L. biflexa cells, by constructing plasmids expressing dCas9 alone or 
along with different sgRNA, aiming at hybridization to the coding and template strand of DNA. Zhao et al.38, 
using the same strategy to obtain gene silencing in S. aureus, demonstrated almost complete gene silencing when 
Figure 7. Flagellar motor switch FliG silencing reduces bacterial motility. (A) L. biflexa colonies containing 
wither pMaOri.dCas9 or pMaOri.dCas9sgRNAfliG were visualized under light microscope and their diameter 
calculated. (B) Graphic shows the average ± standard deviation of 15 colonies of each plate. For statistical 
analysis, diameter values displayed by cells containing dCas9 and sgRNA were compared to the ones displayed 
by cells containing pMaOri.dCas9 plasmid alone by Student’s two-tailed t test (*P < 0.05). (C) Different colonies 
were selected, grown in liquid media and cell extracts of two distinct leptospiral pools were transferred onto 
nitrocellulose membrane, which was probed with mouse anti-recombinant FliG (1:500) and HRP-conjugated 
anti-mouse IgG (1:5,000); after development with chemiluminescent substrate, the same membrane was washed 
and incubate with mouse anti-DnaK antiserum (1:3,000) as loading control.
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sgRNA paired with the coding strand, in contrast to a slight reduction in phenotype when pairing with the sgRNA 
template strand.
In contrast to the lethality of the CRISPR/Cas9 system, L. biflexa cells could survive sgRNA expression along 
with dCas9, corroborating the incapability of DSB repair in the absence of a template DNA and suggesting that no 
off-target in essential genes occurred with the sgRNAs employed. When dCas9 was bound to the β-galactosidase 
gene and base pairing occurred between sgRNA and the coding strand, promising results were obtained: a com-
plete gene silencing was observed, as assessed by enzyme assays and real-time PCR, confirming that indeed, 
dCas9 bound to the target gene hampered RNA polymerase elongation. CRISPRi has been successfully utilized in 
other microorganisms39,42,71–74. Modulating the degree of gene silencing, depending on the DNA strand to which 
sgRNA hybridizes, could be a valuable feature since a gradient of a protein expressed in bacterial cells could ren-
der distinct phenotypes, facilitating the validation of the protein function.
CRISPRi tool could also render satisfactory results when applied for highly expressed genes, e.g., dnaK. 
Interestingly, when we targeted another leptospiral gene, dnaK, no colonies could be recovered when sgRNA 
designed to hybridize to the coding strand was used, a condition in which complete gene silencing was expected. 
These data led us to suggest the essential role of DnaK protein in L. biflexa. Accordingly, random transposon 
libraries in Leptospira failed to recover DnaK-deficient strains9,10, strengthening the necessity of this gene. 
Furthermore, in several other bacteria, DnaK is essential for cell growth not only at elevated temperatures but 
also under optimal conditions, although the reasons for its crucial role are still unclear75.
Flagellar motor switch fliG2 gene knockout by homologous recombination in B. burgdorferi rendered a 
reduced mobility phenotype51, longer time required for colony formation and smaller colonies. L. biflexa possess 
an annotated gene (LEPBI_RS16770) coding for a protein with 70% similarity to borrelial FliG2. CRISPRi gene 
silencing drastically reduced protein expression, which was accompanied by colonies with reduced diameter, 
implying decreased motility. It is the first demonstration that FliG protein is required for leptospiral motility.
Considering the episomal nature of the system, the generation of scape mutants could be an issue when 
applied to pathogenic strain for virulence factor validation, due to host selective pressure; nevertheless, the poten-
tial role of LigA and LigB protein in leptospiral virulence was demonstrated by the expression of episomal TALEs 
utilizing the same backbone (pMaOri)16 and, by our results, gene silencing is maintained when leptospires are 
grown in media with no plasmid selection. Because of pMaOri backbone, plasmids obtained in this work could 
be used to transform Leptospira spp. and currently, we are trying to establish this methodology in the pathogenic 
strain.
In conclusion, we report for the first time, the successful application of the recent CRISPRi methodology in 
Leptospira, expanding the genetic tools for target mutagenesis in these microorganisms. It is anticipated that the 
application of this one-step knockdown system to pathogenic strains will greatly advance our knowledge of the 
basic biology and virulent mechanisms of leptospires.
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